|
|
Volumn 21, Issue 5, 2015, Pages 670-
|
|
Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma
a
a
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GLATIRAMER;
IPILIMUMAB;
METHOTREXATE;
ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
METHYLPREDNISOLONE;
ADULT;
CASE REPORT;
DISEASE ASSOCIATION;
HUMAN;
LETTER;
MALE;
MELANOMA;
METASTATIC MELANOMA;
MIDDLE AGED;
MULTIPLE SCLEROSIS;
RELAPSE;
RISK ASSESSMENT;
TREATMENT OUTCOME;
ATAXIA;
COMPLICATION;
GAIT DISORDERS, NEUROLOGIC;
PARESIS;
RECURRENT DISEASE;
CANCER RECURRENCE;
DEMYELINATION;
DISEASE SEVERITY;
DRUG MEGADOSE;
EXPANDED DISABILITY STATUS SCALE;
GAIT DISORDER;
HEMIPARESIS;
NUCLEAR MAGNETIC RESONANCE IMAGING;
POSITRON EMISSION TOMOGRAPHY;
RISK BENEFIT ANALYSIS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
ATAXIA;
GAIT DISORDERS, NEUROLOGIC;
HUMANS;
MALE;
MELANOMA;
MIDDLE AGED;
MULTIPLE SCLEROSIS, RELAPSING-REMITTING;
PARESIS;
RECURRENCE;
TREATMENT OUTCOME;
|
|
EID: 84952785505
PISSN: 13524585
EISSN: 14770970
Source Type: Journal
DOI: 10.1177/1352458514549403 Document Type: Letter |
|
Times cited : (77)
|
|
References (4)
|
